[1] |
FRAGUAS-SáNCHEZ A I, TORRES-SUáREZ A I.Medical Use of Cannabinoids[J].Drugs, 2018, 78(16):1665-1703
|
[2] |
PAGOTTO U, MARSICANO G, COTA D, et al.The emerging role of the endocannabinoid system in endocrine regulation and energy balance[J].Endocrine Reviews, 2006, 27(1):73-100
|
[3] |
LAPRAIRIE R B, BAGHER A M, DENOVAN-WRIGHT E M.Cannabinoid receptor ligand bias: implications in the central nervous system[J].Current Opinion in Pharmacology, 2017, 32:32-43
|
[4] |
KATCHAN V, DAVID P, SHOENFELD Y.Cannabinoids and autoimmune diseases: A systematic review[J].Autoimmunity Reviews, 2016, 15(6):513-528
|
[5] |
SCHERMA M, MASIA P, SATTA V, et al.Brain activity of anandamide?: a rewarding bliss??[J].Acta Pharmacologica Sinica, 2019, 40(3):309-323
|
[6] |
AYMEN I IDRIS, ROBERT J VAN’T HOF, IAIN R GREIG, SUSAN A RIDGE, DAVID BAKER, RUTH A ROSS S H R.Regulation of bone mass,bone loss and osteoclast activity by cannabinoid receptors[J].Nat Med, 2005, 23(1):1-7
|
[7] |
SHARMA C, SADEK B, GOYAL S N, et al.Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors?: Potential Leads for Drug Discovery and Development[J]. Evidence-Based Complementary and Alternative Medicine, 2015, 2015.
|
[8] |
MACKIE K.Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System[J]. Cannabinoids, 2005, 168: 299-325
|
[9] |
TAM J, OFEK O, FRIDE E, et al.Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling[J].Molecular Pharmacology, 2006, 70(3):786-792
|
[10] |
IDRIS A I, SOPHOCLEOUS A, LANDAO-BASSONGA E, et al.Cannabinoid Receptor Type 1 Protects against Age- Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells[J].Cell Metabolism, 2009, 10(2):139-147
|
[11] |
SAMIR S M, MALEK H A.Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages[J].Journal of Physiology and Pharmacology, 2014, 65(5):687-694
|
[12] |
GALVE-ROPERH I, CHIURCHIù V, DíAZ-ALONSO J, et al.Cannabinoid receptor signaling in progenitorstem cell proliferation and differentiation[J].Progress in Lipid Research, 2013, 52(4):633-650
|
[13] |
EGER M, BADER M, BREE D, et al.Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor[J].Scientific Reports, Springer US, 2019, 9(1):1-8
|
[14] |
IDRIS A I.The promise and dilemma of cannabinoid therapy: lessons from animal studies of bone disease[J]. BoneKEy, 2011, 8: 84.
|
[15] |
PREEDY, VICTOR R.ed. Handbook of Cannabis on PPAR activationby cannabinoids[M]. Handbook of Cannabis and Related Pathologies, 2016.
|
[16] |
RALSTON S H.Genetic Background Modifies the Effects of Type 2 Cannabinoid Receptor Deficiency on Bone Mass and Bone Turnover[J].Calcified tissue international, 2014, 94(3):259-268
|
[17] |
CARNOVALI M, OTTRIA R, PASQUALETTI S, et al.Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease[J]. Pharmacological research, 2016, 104: 1-8.
|
[18] |
QIAN H, ZHAO Y, PENG Y, et al.Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells[J].Journal of Periodontal Research, 2010, 45(4):504-511
|
[19] |
APOSTU D, LUCACIU O, MESTER A, et al.Cannabinoids and bone regeneration[J].Drug metabolism reviews, 2019, 51(1):65-75
|
[20] |
XU A, YANG Y, SHAO Y, et al.Activation of cannabinoid receptor type 2-induced osteogenic differentiation involves autophagy induction and p62-mediated Nrf2 deactivation[J].Cell Communication and Signaling, 2020, 18(1):1-11
|
[21] |
IDRIS A I, SOPHOCLEOUS A, LANDAO-BASSONGA E, et al.Regulation of bone mass,osteoclast function,and ovariectomy-induced bone loss by the type 2 cannabinoid receptor[J].Endocrinology, 2008, 149(11):5619-5626
|
[22] |
OFEK O, KARSAK M, LECLERC N, et al.Peripheral cannabinoid receptor,CB2,regulates bone mass[J].Proceedings of the National Academy of Sciences, 2006, 103(3):696-701
|
[23] |
KHALID A B, GOODYEAR S R, ROSS R A, et al.Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone[J].Cogent Engineering, Cogent, 2015, 138(1):1-9
|
[24] |
SOPHOCLEOUS A, MARINO S, KABIR D, et al.Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition[J].Aging Cell, 2017, 16(5):1051-1061
|
[25] |
MARZO V Di, CRISTINO L.Why endocannabinoids are not all alike[J].Nature neuroscience, 2008, 11(2):124-126
|
[26] |
MANUSCRIPT A.The history of the Drosophila TRP channel: The birth of a new channel superfamily[J].Journal of neurogenetics, 2010, 24(4):216-233
|
[27] |
KANAYA K, IBA K, DOHKE T, et al.TRPV1,ASICs and P2X23 expressed in bone cells simultaneously regulate bone metabolic markers in ovariectomized mice[J].Journal of musculoskeletal & neuronal interactions, 2016, 16(2):145-
|
[28] |
ROSSI F, BELLINI G, TORTORA C, et al.CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity[J]. Pharmacological research, 2015, 99: 194-201.
|
[29] |
ROSSI F, TORTORA C, PUNZO F, et al.The Endocannabinoid Endovanilloid System in Bone[J].International journal of molecular sciences, 2019, 20(8):1919-
|
[30] |
HE L, LIU M, HE Y, et al.TRPV1 deletion impaired fracture healing and inhibited osteoclast and osteoblast differentiation[J]. Scientific reports, 2017, 7: 42385.
|
[31] |
HU K, SUN H, GUI B, et al.TRPV4 functions in flow shear stress induced early osteogenic differentiation of human bone marrow mesenchymal stem cells[J]. Biomedicine & Pharmacotherapy, 2017, 91: 841-848.
|
[32] |
KIM H J, YOON H J, PARK J W, et al.G protein-coupled receptor 119 is involved in RANKL-induced osteoclast differentiation and fusion[J].Journal of Cellular Physiology, 2019, 234(7):11490-11499
|
[33] |
WHYTE L S, RYBERG E, SIMS N A, et al.The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo[J].Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(38):16511-16516
|
[34] |
WHYTE L S, FORD L, RIDGE S A, et al.Cannabinoids and bone: Endocannabinoids modulate human osteoclast function in vitro[J].British Journal of Pharmacology, 2012, 165(8):2584-2597
|
[35] |
SMITH M, WILSON R, O’BRIEN S, et al.The effects of the endocannabinoids anandamide and 2-arachidonoylglycerol on human osteoblast proliferation and differentiation[J].PLoS ONE, 2015, 10(9):1-15
|
[36] |
IDRIS A I, RALSTON S H.Role of cannabinoids in the regulation of bone remodeling[J]. Frontiers in Endocrinology, 2012, 3:136.
|
[37] |
BAB I, ZIMMER A, MELAMED E.Cannabinoids and the skeleton: From marijuana to reversal of bone loss[J].Annals of Medicine, 2009, 41(8):560-567
|
[38] |
SCUTT A, WILLIAMSON E M.Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors[J].Calcified Tissue International, 2007, 80(1):50-59
|
[39] |
JIANG H, WU Y, VALVERDE P, et al.Central Adiponectin Induces Trabecular Bone Mass partly through Epigenetic downregulation of Cannabinoid Receptor CB1[J].Journal of cellular physiology, 2019, 234(5):7062-7069
|
[40] |
DOU Z jun, GAO X L, JIA Y li, et al.CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats[J]. Sleep and Breathing, 2020, 1-9.
|
[41] |
PROTO M C, FIORE D, PISCOPO C, et al.Inhibition of Wntβ-Catenin pathway and Histone acetyltransferase activity by Rimonabant: A therapeutic target for colon cancer[J].Scientific Reports, 2017, 7(1):1-14
|
[42] |
SMOUM R, BARAGHITHY S, CHOURASIA M, et al.CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency[J].Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(28):8774-8779
|